|
|
Vaccine Detail
|
CV2CoV |
| Vaccine Information |
- Vaccine Name: CV2CoV
- Target Pathogen: SARS-CoV-2
- Target Disease: COVID-19
- Vaccine Ontology ID: VO_0005168
- Type: RNA vaccine
- Status: Clinical trial
- Host Species for Licensed Use: Human
- Immunization Route: Intramuscular injection (i.m.)
- Description: A SARS-CoV-2 mRNA vaccine developed by CureVac AG and CEPI (NCT04449276)
|
| Host Response |
|
|
| References |
NCT04449276: A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults [https://clinicaltrials.gov/ct2/show/NCT04449276]
|
|
